>
Wash Post Editorial Board Turns Against Climate Agenda?!
One Year Ago I Predicted and Described in Detail Huge Mars AI Plans that Elon Musk Confirmed...
British Teachers To "Spot Misogyny" In Boys And Target Them For Reeducation
Democrats Refuse To Release Post-Mortem Of 2024 Election Loss, DNC Chair Says
This tiny dev board is packed with features for ambitious makers
Scientists Discover Gel to Regrow Tooth Enamel
Vitamin C and Dandelion Root Killing Cancer Cells -- as Former CDC Director Calls for COVID-19...
Galactic Brain: US firm plans space-based data centers, power grid to challenge China
A microbial cleanup for glyphosate just earned a patent. Here's why that matters
Japan Breaks Internet Speed Record with 5 Million Times Faster Data Transfer
Advanced Propulsion Resources Part 1 of 2
PulsarFusion a forward-thinking UK aerospace company, is pushing the boundaries of space travel...
Dinky little laser box throws big-screen entertainment from inches away
'World's first' sodium-ion flashlight shines bright even at -40 ºF

3 patients experienced complete remission after regularly taking fenbendazole.
But the cancer industry seems to hate it because it only costs about $11 per week.
Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects.
The case series highlights the remarkable stories of three cancer patients who achieved miraculous recoveries with fenbendazole after exhausting all conventional therapies.
After analyzing these cases, the abstract concluded, "FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies."
Adding to the growing evidence in support of fendendazole's use case against cancer, an Oklahoma man credited his miraculous cancer recovery to the pet med after overcoming terminal small cell lung cancer, defying a less than 1% survival rate and leaving doctors baffled.
This story is truly remarkable. Watch.